O N Lipometaplasia in fibrous hyperplasia and inflammatory fibrous hyperplasia of the oral cavity Fibrous hyperplasia (FH) is a reactive hyperplastic lesion of the connective tissue, being considered the most common intraoral lesion.When an inflammatory component is detected, usually on microscopic analysis, it is diagnosed as inflammatory FH (IFH). FH/IFH affects predominantly adult women. Clinically, it presents as a yellowish-white or normal-appearing mucosal-colored, sessile or pedunculated, irregular or smooth-surfaced nodular lesion, preferentially located on alveolar ridge, buccal mucosa, gingiva, tongue, and lips. Moreover, hyperkeratotic, erythematous, or ulcerated surface, owing to repeated trauma, is often observed in IFH cases. The pathogenesis is often associated with chronic (low-intensity) irritating factors such as illfitting prostheses, fractured teeth, retained root remnants, parafunctional habits, poor oral hygiene, and occlusal trauma. [1][2][3] Microscopically, oncocytic, squamous, chondromatous, and osseous metaplasia in IFH cases has been described. 1-3 However, we have detected lipometaplasia (adipose metaplasia) in typical FH/IFH cases, which led us to carry out a comprehensive study in order to determine their clinicopathological features.This study was approved by the Ethics Committee (92272218.5.0000.5419). We retrospectively assessed 792 cases diagnosed as intraoral FH/IFH, between 2010 and 2021. Patient data such as gender, age, location of the lesion, and associated local irritating factor were obtained from dental records. Archived slides stained with hematoxylin and eosin (H&E), obtained from Oral Histopathology